首页> 外国专利> NON-INVASIVE IMAGING METHOD FOR EARLY DETECTION AND MAPPING THE SEVERITY OF DISEASES BY USING CEST MRI

NON-INVASIVE IMAGING METHOD FOR EARLY DETECTION AND MAPPING THE SEVERITY OF DISEASES BY USING CEST MRI

机译:CEST MRI早期发现和映射疾病严重程度的无创成像方法

摘要

A non-invasive CEST MRI imaging method is disclosed for early detection and mapping the severity of diseases by using MRI. The endogenous magnetic resonance image (MRI) contrast of the biological tissue can rely on the endogenous protons of the proteins and peptides as a source of the contrast, such as hydroxyl, amine, and amide protons, and thereby provide imaging of the accumulation of amyloid beta, accumulation of neurofibrillary tangles, aggregation proteins and peptides, the hypoxia in cancer and non-cancer tissue, the tissues atrophy, distinguish the edema from the tumor, determine tumor boundary, monitor response of tumor to treatment and detect lower grade tumor by using endogenous protons contrast via CEST MRI. The difference in CEST images signals is used to detect and map severity of the diseases and predict response to treatment. The method works without contrast agents or tracers.
机译:公开了一种非侵入性的CEST MRI成像方法,用于通过使用MRI来早期检测和绘制疾病的严重程度。生物组织的内源性磁共振图像(MRI)对比可以依靠蛋白质和多肽的内质子作为对比的来源,例如羟基,胺和酰胺质子,从而提供淀粉样蛋白积聚的成像β,神经原纤维缠结,聚集蛋白和肽的积累,癌症和非癌组织中的缺氧,组织萎缩,从肿瘤中区分出水肿,确定肿瘤边界,监测肿瘤对治疗的反应并通过检测低级肿瘤内源性质子通过CEST MRI进行对比。 CEST图像信号中的差异用于检测和绘制疾病严重程度并预测对治疗的反应。该方法无需造影剂或示踪剂即可工作。

著录项

  • 公开/公告号US2019128981A1

    专利类型

  • 公开/公告日2019-05-02

    原文格式PDF

  • 申请/专利权人 ISHTAR FAISAL ALGBURI;

    申请/专利号US201816172502

  • 发明设计人 ISHTAR FAISAL ALGBURI;

    申请日2018-10-26

  • 分类号G01R33/48;G01R33/56;A61K38/17;

  • 国家 US

  • 入库时间 2022-08-21 12:06:11

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号